Artiva Biotherapeutics (ARTV) Return on Equity (2024 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Return on Equity for 2 consecutive years, with 0.7% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity fell 38.0% to 0.7% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.7%, a 38.0% decrease, with the full-year FY2025 number at 0.57%, up 474.0% from a year prior.
  • Return on Equity was 0.7% for Q4 2025 at Artiva Biotherapeutics, down from 0.57% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.22% in Q2 2024 to a low of 11.56% in Q3 2024.